CenterBook Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
3,637
-8,686
-70% -$2.85M 0.06% 345
2025
Q4
$4.32M Buy
12,323
+245
+2% +$82.8K 0.21% 127
2025
Q3
$3.9M Buy
12,078
+2,033
+20% +$632K 0.19% 144
2025
Q2
$3.91M Buy
10,045
+7,223
+256% +$2.91M 0.22% 127
2025
Q1
$1.23M Sell
2,822
-33,890
-92% -$13.6M 0.08% 284
2024
Q4
$13.5M Buy
36,712
+30,954
+538% +$13M 0.81% 23
2024
Q3
$2.99M Sell
5,758
-2,071
-26% -$1.11M 0.18% 142
2024
Q2
$4.24M Buy
+7,829
New +$4.14M 0.26% 145
2023
Q1
Sell
-3,732
Closed -$1.91M 407
2022
Q4
$1.91M Buy
3,732
+1,000
+37% +$508K 0.32% 106
2022
Q3
$1.24M Buy
2,732
+1,348
+97% +$645K 0.24% 145
2022
Q2
$668K Buy
1,384
+261
+23% +$129K 0.14% 244
2022
Q1
$552K Buy
1,123
+685
+156% +$313K 0.2% 186
2021
Q4
$203K Buy
+438
New +$184K 0.12% 266

Other funds holding ELV

CenterBook Partners's ELV Position: Q1 2026 in Review

CenterBook Partners reduced its Elevance Health (ELV) stake by 70% in Q1 2026, selling an estimated $2.85M and leaving 3,637 shares worth $1.06M. The position accounts for 0.06% of the portfolio, ranked #345.

CenterBook Partners first reported a position in ELV in Q4 2021 and has held it in 13 quarters since. The position peaked at $13.5M in Q4 2024. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • CenterBook Partners held 3,637 shares of Elevance Health worth $1.06M as of Q1 2026.
  • CenterBook Partners sold 8,686 Elevance Health shares in Q1 2026, an estimated $2.85M.
  • Elevance Health made up 0.06% of CenterBook Partners's portfolio in Q1 2026, its #345 holding.
  • CenterBook Partners first reported a position in Elevance Health in Q4 2021 and has held it in 13 quarters since.
  • CenterBook Partners's Elevance Health position peaked at $13.5M in Q4 2024.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.